Bliss GVS Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Dec' 23	Sep' 23	Jun' 23	Mar' 23	Dec' 22

Sales

161.33

171.32

108.99

143.42

168.79

Operating profit

28.66

42.31

11.05

10.91

33.46

Interest

1.79

1.18

1.31

4.97

1.20

Gross profit

34.77

51.74

16.27

12.42

43.68

EPS (Rs)

1.98

3.25

0.72

0.59

2.81

Other income

7.90

10.61

6.53

6.48

11.42

Stock adjustment

5.26

-5.27

-7.22

12.10

2.27

Raw material

80.60

83.56

63.17

66.87

78.76

Power and fuel

-

-

-

-

-

Employee expenses

20.97

20.40

20.34

18.87

18.33

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

25.85

30.31

21.65

34.67

35.97

Provisions made

-

-

-

-

-

Depreciation

6.25

5.68

5.36

3.97

3.79

Taxation

7.80

12.18

3.41

2.34

10.61

Net profit / loss

20.72

33.89

7.50

6.11

29.28

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

10.47

10.44

10.42

10.42

10.42

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

17.76

24.70

10.14

7.61

19.82

GPM (%)

20.54

28.44

14.08

8.28

24.24

NPM (%)

12.24

18.63

6.49

4.07

16.25